Do Sangamo Therapeutics Inc (NASDAQ: SGMO) Fit In A Value Investing Philosophy?
Currently, there are 208.65M common shares owned by the public and among those 199.04M shares have been available to trade. The company’s stock has a 5-day price change of -29.63% and 133.07% over the past three months. SGMO shares are trading 249.71% year to date (YTD), with the 12-month market performance up to 441.77% higher. […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Loses -3.37% From High. Why That Could Change?
Currently, there are 208.22M common shares owned by the public and among those 198.63M shares have been available to trade. The company’s stock has a 5-day price change of 52.66% and 160.91% over the past three months. SGMO shares are trading 428.25% year to date (YTD), with the 12-month market performance up to 655.26% higher. […]
Reviewing The Case For Sangamo Therapeutics Inc (SGMO) Going Higher
Currently, there are 208.22M common shares owned by the public and among those 198.63M shares have been available to trade. The company’s stock has a 5-day price change of -14.71% and 75.72% over the past three months. SGMO shares are trading 220.27% year to date (YTD), with the 12-month market performance up to 278.26% higher. […]
Do Sangamo Therapeutics Inc (NASDAQ: SGMO) Fit In A Value Investing Philosophy?
Currently, there are 208.22M common shares owned by the public and among those 198.84M shares have been available to trade. The company’s stock has a 5-day price change of 62.92% and 63.63% over the past three months. SGMO shares are trading 176.09% year to date (YTD), with the 12-month market performance up to 212.50% higher. […]
Sangamo Therapeutics Inc (SGMO) Volatility Spurs A Quest For Clarity
Currently, there are 208.22M common shares owned by the public and among those 198.84M shares have been available to trade. The company’s stock has a 5-day price change of 24.60% and 116.07% over the past three months. SGMO shares are trading 122.71% year to date (YTD), with the 12-month market performance up to 134.77% higher. […]
Value Hunters: Look To Sangamo Therapeutics Inc (SGMO)
Currently, there are 208.22M common shares owned by the public and among those 198.84M shares have been available to trade. The company’s stock has a 5-day price change of 15.58% and 101.74% over the past three months. SGMO shares are trading 70.66% year to date (YTD), with the 12-month market performance up to 87.31% higher. […]
Sangamo Therapeutics Inc (NASDAQ: SGMO): Do Not Miss The Gain Train
Sangamo Therapeutics Inc (SGMO) concluded trading on Thursday at a closing price of $0.86, with 3.22 million shares of worth about $2.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 41.76% during that period and on September 25, 2024 the price saw a […]
Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Handle With Care: Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Sangamo Therapeutics Inc (NASDAQ:SGMO) by 1.13%. After grabbing 12.41 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.00% having worth around $5.34 million. […]
